Industry News (Blood Conservation)

Technology To Save Blood During Surgery Cleared by FDA

Published in Blood Weekly, March 18th, 1996

The blood management business of Medtronic, Inc., Minneapolis, Minnesota, announced that the U.S. Food and Drug Administration (FDA) has cleared for commercial release the Sequestra 1000, a blood processing system used to conserve blood during major surgery.

A blood processing system recovers blood shed during heart surgery, transplant surgery and as a result of trauma. The Sequestra 1000 performs autotransfusion, a process in which a patient's blood is cleansed and held for subsequent use, thereby minimizing use of banked blood and reducing concern about transmission of bloodborne diseases.

In addition to conventional autotransfusion, the Sequestra...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1996-03-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry